Ritter Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

14,030

0.25%

07/31/2018

iShares Core S&P Total US Stock Market ETF

9,527

0.17%

09/06/2018

DFA US Targeted Value Portfolio

4,495

0.08%

4,495

04/30/2018

Fidelity Spartan Extended Market Index Fund

2,961

0.05%

07/31/2018

1,106

0.02%

0.01%

09/05/2018

View Profile

Address	1880 Century Park East Los Angeles California 90067 United States
Employees	-
Website	http://www.ritterpharmaceuticals.com
Updated	07/08/2019
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J.